SAMANTHA SUMMERLIN: Open Payments
NPI 1952076291 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 66 payments from 13 companies in 2025. Trend: 2023 $1,885 · 2024 $1,715 · 2025 $1,289
Food & beverage: $1,205Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $445 |
| Janssen Biotech, Inc. | 9 | $187 |
| Madrigal Pharmaceuticals | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Phathom Pharmaceuticals, Inc. | 6 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| GENZYME CORPORATION | 2 | $56 |
| Novo Nordisk Inc | 2 | $54 |
| PFIZER INC. | 3 | $47 |
| Organon LLC | 2 | $47 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, ENTYVIO, SKYRIZI, VOQUEZNA, XIFAXAN, DUPIXENT.
Industry payments across GA — which companies pay providers there.
